DSS, Inc.'s Form 4 filing
Impact Biomedical Inc. (IBO) · filed Sep 18, 2024
- Accession no.
- 0001493152-24-037044
- Filed
- Sep 18, 2024
- Trade date
- Sep 16-17, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $153.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DSS, Inc.CIK 0000771999 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $2.69 | +$134,500 | 50,000 | Indirect | |
| Sep 17, 2024 | Common Stock | PPurchaseAcquired | +7,800 | $2.40 | +$18,720 | 57,800 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.